Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/1999
03/25/1999WO1998050577A9 A method and a system for determination of somatic cells in milk
03/25/1999WO1998050530A9 Enzymatic nucleic acids: synthesis, selection and use
03/25/1999WO1998024928A3 Detection of chromosomal abnormalities
03/25/1999DE19741716A1 Recognition system
03/25/1999DE19741715A1 New pentopyranosyl nucleoside compounds
03/25/1999DE19741714A1 Hybridisation-independent nucleic acid synthesis and amplification
03/25/1999DE19741084A1 New library of chemically modified nucleic acid molecules
03/25/1999CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas
03/25/1999CA2334007A1 Method of monitoring the competitiveness of a microbial strain
03/25/1999CA2304368A1 Reagents and methods useful for detecting diseases of the prostate, breast and ovary
03/25/1999CA2304349A1 The porcine adipocyte fatty acid-binding protein encoding gene and methods to localise, identify or mark genes or alleles or quantitative trait loci of farm animals
03/25/1999CA2304170A1 P53-induced apoptosis
03/25/1999CA2304011A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999CA2303945A1 Detection of minimal residual disease in lymphoid malignancies
03/25/1999CA2303908A1 Chemical modification of dna using peptide nucleic acid conjugates
03/25/1999CA2303907A1 Method for selection of insertion mutations
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303790A1 Characterising nucleic acid by mass spectrometry
03/25/1999CA2303759A1 Cyclin-dependent kinase inhibitors and uses thereof
03/25/1999CA2303463A1 Hybridization probes which differentiate between streptomycetes and maduromycetes
03/25/1999CA2303461A1 Capacity affinity sensor
03/25/1999CA2303441A1 Interference free biosensor
03/25/1999CA2303397A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections
03/25/1999CA2303299A1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
03/25/1999CA2303227A1 Human prl-1 phosphatase
03/25/1999CA2303225A1 Dna30942 polypeptide, a tnfr homolog
03/25/1999CA2302782A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999CA2302533A1 De novo polynucleotide synthesis using rolling templates
03/25/1999CA2302432A1 Dna bracketing locus compatible standards for electrophoresis
03/25/1999CA2302193A1 Techniques for identifying, confirming, mapping and categorizing polymers
03/25/1999CA2301828A1 Thermostable luciferases and methods of production
03/25/1999CA2299414A1 Genetic polymorphisms in the microsomal triglyceride transfer protein promoter and uses thereof
03/25/1999CA2297005A1 Method for determining propensity for developing late-onset alzheimer's disease
03/25/1999CA2296045A1 Persephin and related growth factors
03/25/1999CA2244978A1 Novel alcohol dehydrogenase
03/25/1999CA2244971A1 Mure
03/25/1999CA2244967A1 Murf
03/25/1999CA2244954A1 Murf
03/24/1999EP0903583A2 Reduction in first slide bias and improved enzyme stability by incorporation of diaryl tellurides in the gravure layer of dry-film immunoassay elements
03/24/1999EP0903411A2 Fluorescent material labeled-probe and method for detecting hybridization
03/24/1999EP0903410A1 Method for detection and determination of enzymatic reactions in urine
03/24/1999EP0903409A2 Aminopeptidase (AmpS)
03/24/1999EP0903407A2 Streptococcus pneumoniae phoH gene
03/24/1999EP0902888A1 Method and apparatus for sensing the presence of microbes
03/24/1999EP0902885A1 Systems and methods for detection of labeled materials
03/24/1999EP0902840A2 Malignant human cell transformation detection method
03/24/1999EP0902839A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells
03/24/1999EP0902837A1 Tailless nuclear hormone receptor (tlx receptor)
03/24/1999EP0902835A1 Purification of pharmaceutical-grade plasmid dna
03/24/1999EP0902791A1 Extracellular/epidermal growth factor hcaba58x
03/24/1999EP0796345B1 An apparatus for performing magnetic cycle reaction
03/24/1999EP0750627A4 Transgenic animal assay system for anti-cholinesterase substances
03/24/1999EP0722507A4 Detection of amplified or deleted chromosomal regions
03/24/1999EP0614493B1 Method for reducing false positive signals in an rna amplification system
03/24/1999CN1212053A Method for monitoring biological activity in fluids
03/24/1999CN1212021A Method and compositions for determining sequence of nucleic acid molecules
03/24/1999CN1212020A Method and compositions for analyzing nucleic acid molecules utilizing sizing techniques
03/24/1999CN1212019A Method and compositions for detecting binding of ligand pair using non-fluorescent label
03/24/1999CN1211736A Use of certain amides as probes for detection of antitubulin activity and resistance monitoring
03/24/1999CA2216686A1 Allelic variants of the phospholipase c-gamma1 gene associated with bipolar disorder
03/23/1999US5886903 Method and knowledge-based system for diagnosis in biological treatment of waste water
03/23/1999US5886238 Alkene precursors for preparing chemiluminescent dialkyl-substituted 1,2-dioxetane compounds
03/23/1999US5886177 Phosphate linked oligomers
03/23/1999US5886150 Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof
03/23/1999US5885970 Antisense oligonucleotides against human protein kinase C
03/23/1999US5885840 Utilizing cell positions as a factor in merging data measurement, change in lasers, use of different cell dye strains and different treating reagents provides additional data regarding cells of the sample; laser scanning cytometry
03/23/1999US5885836 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
03/23/1999US5885834 Inducing apoptosis in cell by identifying phosphodiesterase pde1b1 in cell line comprising said cancer cell, synthesizing antisense oligodeoxynucleotide asodn inhibitor to bind to mrna coding pde1b1, applying asodn to cell to induce apoptosis
03/23/1999US5885823 Bacteria strain atcc no.55783 are incubated in an oxygen concentration of from about 0 percent to about 18 percent, agitating the bacteria in suspension; veterinary medicine
03/23/1999US5885813 Thermostable DNA polymerases
03/23/1999US5885805 gbpA
03/23/1999US5885804 Genetic engineered polynucleotides and encoded polypeptides of the atp-binding protein family, treating meningitis, infection of cerebrospinal fluid
03/23/1999US5885799 Hepatitis C virus protease
03/23/1999US5885795 Methods of expressing angiostatic protein
03/23/1999US5885791 Quantitative analysis of determining the minimum inhibitory concentration of sample microbiocides; color analysis
03/23/1999US5885790 Indictor consists of an oxidase and/or peroxidase enzyme, 3-methyl-6(m-sulfonate)-bezothiazolinone-(2)-hydrazone, a second dye selected from 3,3-dimethylaminobenzoic acid, 3,5-dichoro-2-hydroxybenzosulfonic acid and others
03/23/1999US5885789 Spectrophotometry; useful for qualitative or quantitative analysis of hemoglobin obtained from bodily fluid
03/23/1999US5885784 Process for making triglyceride controls, calibrators and standards comprising novel triglyceride substitutes
03/23/1999US5885783 Autoimmune inner ear disease antigen and diagnostic assay
03/23/1999US5885782 Microbiocide oligopeptide mixture comprising at least two amino acid sequences; fungicides for treating plant or human
03/23/1999US5885779 Repressed trans-activator system for characterization of protein-protein interactions
03/23/1999US5885778 Using the dyes in dna analysis, dna sequence determination
03/23/1999US5885777 A nucleotide sequence encoding an active phosphatidylinositol-3-kinase consisting of specific amino acid sequences or a nucleotide sequence which hybridizes with above nucleotide sequences after washing in low salt buffer
03/23/1999US5885775 Methods for determining sequences information in polynucleotides using mass spectrometry
03/23/1999US5885772 Method for the detection of anencephaly
03/23/1999US5885770 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them
03/23/1999US5885769 Transformed cell lines containing a reporter gene operatively linked to a genetic control element that is responsive to growth factor stimulated cell proliferation and/or oncogene mediated neoplastic transformation
03/23/1999US5885768 Immunogenic peptides derived from the orf1, orf2, and orf3 regions of hepatitis e virus (hev), diagnostic reagents containing the peptide antigens, vaccine compositions containing the antigens, antibodies
03/23/1999US5885767 Methods and compositions for quantitating L-homocysteine and/or l-methionine in a solution
03/23/1999US5885572 Administering polypeptide or active fragment to treat bacterial infections
03/23/1999CA1340460C Electrochemiluminescent rhenium moieties and methods for their use
03/22/1999CA2244237A1 A human lig-1 homolog (hlig-1)
03/19/1999CA2247648A1 Method for the detection and for the determination of enzymatic reactions in urine
03/19/1999CA2244880A1 Synuclein-based assay and novel synuclein protein
03/19/1999CA2216595A1 A novel three-step method for early diagnosis of autoimmunity and primary central nervous system b-cell lymphoma
03/19/1999CA2216057A1 Polymorphic cag repeat-containing gene, diagnosis of psychiatric diseases and therapeutic uses thereof
03/19/1999CA2215870A1 Method for the identification of essential genes and therapeutic targets
03/19/1999CA2211003A1 Human tumor necrosis factor receptor
03/18/1999WO1999013338A1 dsRNA/dsRNA-BINDING PROTEIN METHODS AND COMPOSITIONS
03/18/1999WO1999013334A2 Method for diagnosing preliminary stages of cancer of the liver and kidney
1 ... 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 2661 2662 2663 2664 2665 2666 ... 3003